Navigation Links
IRIDEX Reports 2013 Second Quarter Results; $9.2 Million Record Q2 Revenue
Date:8/1/2013

>

President and CEO Will Moore said, "Sales of both consumable products and systems continued to be strong in the second quarter, including solid contributions from our licensing and distribution partner and from the Peregrine distribution agreement announced in April. The repositioned IRIDEX is now thinking and executing like a commercial organization and the benefits of that orientation are becoming clear in the financial results."

Moore continued, "While we are not yet at the tipping point in the broad industry, the upside for our MicroPulse™ technology continues to grow for both Diabetic Macular Edema and more recently for Glaucoma. Literally dozens of clinical publications – most without any financial support from the Company – have been presented or printed in the past 6 months. Physicians are not only adopting the technology in growing numbers, they are anxious to drive the technology into new areas of therapy due to the safety and efficacy of MicroPulse. We couldn't be happier with the efforts of leading physicians in the field that are pushing the use of our technology forward to the benefit of patients and the healthcare system. The refrain we are hearing is that the system can simply no longer support the use of drug-only treatment regimens with the advent of MicroPulse tissue sparing laser options."

During the second quarter 2013, the Company continued to execute its share repurchase program. Approximately 17,000 shares have been repurchased at an average price of $4.50 under the plan approved in February 2013.

1H 2013 Business Highlights

  • The Company converted all outstanding shares of its Series A Preferred Stock into 1,000,000 shares of its common stock. The Series A Preferred shares were issued to BlueLine Capital Partners LP (BlueLine) as part of a private placement agreement that occurred in 2007. The Certificate of Designation provided that the Series A Preferred shares automatically converted into
    '/>"/>

  • SOURCE IRIDEX Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
    2. IRIDEX Reports 2012 First Quarter Results
    3. IRIDEX Announces Second Quarter 2012 Conference Call and Release Date
    4. IRIDEX Reports 2012 Second Quarter Results
    5. IRIDEX Appoints Chairman William M. Moore as Interim President & CEO
    6. IRIDEX Announces Third Quarter 2012 Conference Call and Release Date
    7. IRIDEX Reports 2012 Third Quarter Results
    8. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
    9. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
    10. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
    11. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... , Sept. 2, 2015 Amgen ... of a Marketing Authorization Application (MAA) to the ... for etelcalcetide (formerly AMG 416) for the treatment ... chronic kidney disease (CKD) on hemodialysis therapy. If ... that can be administered intravenously. Etelcalcetide ...
    (Date:9/2/2015)... 2, 2015   Gulf Coast Tattoo Removal is the ... cutting-edge Astanza Duality laser in Southern Mississippi . ... tattoo regret and take back control of their skin. The clinic ... its services to Biloxi , Gulfport ... tattoo regret being as prevalent as it is, I was surprised ...
    (Date:9/2/2015)... Sept. 2, 2015 Research and Markets ... the "An Introduction to Medical Device Software: ... 2015)" conference to their offering. ... to the regulations and requirements that apply to ... interactive, using real life examples and state-of- the-art ...
    Breaking Medicine Technology:Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 6Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 7Gulf Coast Tattoo Removal Delivers Unrivaled Tattoo Removal Results To Biloxi And Gulfport With Astanza Duality 2An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2
    ... International, Inc. (Nasdaq: BDSI ) today announced ... buccal soluble film) in Canada will take place this ... is approved in the U.S., Canada, and the E.U. ... management of breakthrough pain in opioid tolerant, adult patients ...
    ... 20, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: ... China-based biotechnology company focused on researching, developing, manufacturing ... annual general meeting of shareholders of 3SBio Inc. ... 10:00 a.m., Shenyang time, at our executive office, ...
    Cached Medicine Technology:BioDelivery Sciences Announces Commercial Launch of ONSOLIS in Canada 2BioDelivery Sciences Announces Commercial Launch of ONSOLIS in Canada 33SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011 2
    (Date:9/2/2015)... ... September 02, 2015 , ... Density measurement is used in ... sample handling makes density measurements more efficient and error-free. The new METTLER TOLEDO ... workflow and the advantages compared to manual sample handling. , The Evolution of ...
    (Date:9/2/2015)... ... September 02, 2015 , ... Michael Elliot Media announces a crowdfunding ... actress as the primary love interest in the film. The campaign is being called ... affects how and what we think,” Michael Elliot, an award-winning screenwriter and CEO of ...
    (Date:9/2/2015)... , ... September 02, 2015 , ... ... combining both naturopathic and allopathic medicine, opens its second location this week at ... features roughly 1000 square feet of lounge space for patients to relax while ...
    (Date:9/2/2015)... (PRWEB) , ... September 02, ... ... the nation’s largest and fastest-growing interim clinical staffing companies, has completed a ... Heritage Group.         , BPOC and Heritage Group each offer extensive ...
    (Date:9/2/2015)... , ... September 02, 2015 , ... ... announced today. The two day international investment and business conference will be hosted ... 2015 in Beijing China. The full-weekend networking conference will feature leading EB-5 industry ...
    Breaking Medicine News(10 mins):Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2
    ... into consideration the epidemic that is bird flu which is ... in aid to Turkey.// ,This follows a high level ... this bore fruit and according to latest reports World Bank ... aid. ,As said by Jurgen Voegele, Bank's Eastern Rural ...
    ... control measures to avoid infected poultry entering Germany from ... flu infection Turkish poultry// reported Germany Agricultural Minster Horst ... Germany to take stringent measures to avoid bird flu ... held in Berlin. German government will take strict legal ...
    ... say that the long winter might make people depressed and ... their winter blues//. ,Jane Kinyon, a clinical professor ... common to suffer from mild irritation and depression during the ... temperatures. But this should not dampen one’s spirit and discourage ...
    ... were to be reclassified again, according to campaigners. The UK’s ... the drug //is connected to mental disorders. This may result ... three years. It had been classified as a Class C ... to the use of the drug has to be conducted, ...
    ... the number of people suffering from stress and other related ... the stress levels // of 28 participants. ,They ... saliva cortisol levels are the best indicators of one’s stress ... after they spent their lunch hour viewing art. It was ...
    ... Oral and pharyngeal cancers are by far the leading ... these are not discovered until too late and thus ... sacrificing a large amount of tissue leading to ... collaborating with the American Dental Association (ADA) to build ...
    Cached Medicine News:
    ... Accurately tests for Nystagmus when ... 10" high by 8" diameter. Light ... ball bearings for effortless spin mechanism. ... from patient. Includes both Adult and ...
    Diagnose dry eye, assess the effectiveness of permanent punctal occlusion, collagen - dissolvable in 3-5 days, all are 2 mm long. Sterile...
    Clear Base Stand Magnifiers are ideal for any visual task that requires high magnification....
    Contour design eyelid implants....
    Medicine Products: